Christopher P. Lee
9Patents
9h-index
33Co-inventors
65Inventor score
Filing activity: Apr 25, 2003 → Jun 19, 2014
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7452901B2 | Anti-cancer phosphonate analogs | Chemistry; Metallurgy | 69 | Expired |
| US7645747B2 | Therapeutic phosphonate compounds | Chemistry; Metallurgy | 57 | Expired |
| US8022083B2 | Antiviral phosphonate analogs | Emerging Cross-Sectional Technologies | 44 | Active |
| US8871785B2 | Antiviral phosphonate analogs | Emerging Cross-Sectional Technologies | 33 | Active |
| US7462608B2 | Non nucleoside reverse transcriptase inhibitors | Physics | 29 | Expired |
| US9139604B2 | Antiviral phosphonate analogs | Emerging Cross-Sectional Technologies | 26 | Active |
| US7429565B2 | Antiviral phosphonate analogs | Emerging Cross-Sectional Technologies | 24 | Expired |
| US7470724B2 | Phosphonate compounds having immuno-modulatory activity | Human Necessities | 23 | Expired |
| US7432261B2 | Anti-inflammatory phosphonate compounds | Chemistry; Metallurgy | 23 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.